Autolus Therapeutics to Participate in Upcoming Investor Conferences
Autolus Therapeutics to Participate in Upcoming Investor Conferences
LONDON and GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announced that the Company will participate in two upcoming investor conferences. 25th Annual Needham Virtual Healthcare ConferenceDate and time: April 13, 2028; 10:15am EDT / 3:15pm BSTPresenter: Chief Executive Officer Dr. Christian Itin A webcast of the presentation will be available...